Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Tamer Khashab"'
Autor:
Rohit Mathur, Lalit Sehgal, Ondrej Havranek, Stefan Köhrer, Tamer Khashab, Neeraj Jain, Jan A. Burger, Sattva S. Neelapu, R. Eric Davis, Felipe Samaniego
Publikováno v:
Haematologica, Vol 102, Iss 2 (2017)
Histone methylation and demethylation regulate B-cell development, and their deregulation correlates with tumor chemoresistance in diffuse large B-cell lymphoma, limiting cure rates. Since histone methylation status correlates with disease aggressive
Externí odkaz:
https://doaj.org/article/324241508f5049fc9285464248a7b769
Autor:
Felipe Samaniego, Asif Rashid, Boris Blechacz, Anita L. Sabichi, Lei Feng, Xue Ao, Rong-Hua Tao, Tamer Khashab, Lalit Sehgal, Rohit Mathur, Zuzana Berkova, Haifeng Zhu
Supplementary figure legends and materials
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dab0254a818c31b3390df0b77e6be1ca
https://doi.org/10.1158/1541-7786.22513642.v1
https://doi.org/10.1158/1541-7786.22513642.v1
Autor:
Felipe Samaniego, Asif Rashid, Boris Blechacz, Anita L. Sabichi, Lei Feng, Xue Ao, Rong-Hua Tao, Tamer Khashab, Lalit Sehgal, Rohit Mathur, Zuzana Berkova, Haifeng Zhu
Supplementary figure 1-2: Fig. S1. Fas mRNA in HCC cell lines and the effects of HuR knockdown on alternative Fas splicing. Fig S2. Effect of HuR knock-down on FasL-induced apoptosis in HepG2 cells.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45ef6b28cea294e43132e349e06d8cbc
https://doi.org/10.1158/1541-7786.22513645
https://doi.org/10.1158/1541-7786.22513645
Autor:
Georgios I. Laliotis, Elizabeth M. Muhowski, Fazal Shirazi, Ondrej Havranek, Satishkumar Singh, Lalit Sehgal, Tereza Chrbolkova, Amber Hart, Kristyna Kupcova, Tamer Khashab, Jiangjiang Zhu, Anuvrat Sircar, Jennifer A. Woyach, Lapo Alinari, Sayan Mullick Chowdhury, Robert A. Baiocchi, Felipe Samaniego, Neeraj Jain, Ram Kumar Singh, Philip N. Tsichlis
Publikováno v:
Blood Adv
Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma; 40% of patients relapse after a complete response or are refractory to therapy. To survive, the activated B-cell (ABC) subtype of DLBCL relies upon B-cell recep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8970b655e8edb7bcde627e96bb2e223
https://doi.org/10.1182/bloodadvances.2020001685
https://doi.org/10.1182/bloodadvances.2020001685
Autor:
Tamer Khashab, Michael E. Scheurer, Neda Zarrin-Khameh, Heidi Dowst, Anna Ewa Schwarzbach, Maria A Berezina, Michael Brooks, Attiya B. Noor, Martha P. Mims, Samantha Cohen, Salma Kaochar, Alexander D Le, Guilherme Godoy, Nicholas Mitsiades
Publikováno v:
Cancer Research. 81:549-549
Background: AA men have higher PC incidence and mortality than white men. Healthcare access and other socioeconomic factors contribute to these disparities. The high cost of NGS can become an additional factor for disparity. Indeed, minority and unin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a5b53d2fc263ae35158d4cfcf0d4469
https://doi.org/10.1158/1538-7445.am2021-549
https://doi.org/10.1158/1538-7445.am2021-549
Autor:
Neeraj Jain, Fazal Shirazi, Lalit Sehgal, Ram Kumar Singh, Tamer Khashab, Ondrej Havranek, Felipe Samaniego
Diffuse large B-cell lymphoma is the most common subtype of non-Hodgkin lymphoma; 40% of patients relapse following a complete response or are refractory to therapy. The activated subtype of diffuse large B-cell lymphoma relies upon B-cell receptor s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af4c34ed7f7a70403fa84078aa4398b6
https://doi.org/10.1101/523761
https://doi.org/10.1101/523761
Autor:
Heidi Dowst, Guilherme Godoy, Samantha Cohen, Anna Ewa Schwarzbach, Alexander D Le, Attiya Batool Noor, Maria A Berezina, Tamer Khashab, Michael Brooks, Nicholas Mitsiades, Neda Zarrin-Khameh, Martha P. Mims, Salma Kaochar, Michael E. Scheurer
Publikováno v:
Journal of Clinical Oncology. 39:16-16
16 Background: African American (AA) men have higher prostate cancer (PC) incidence and PC-specific mortality than non-AA men. Socioeconomic/healthcare access and environmental factors contribute to the disparity in clinical outcomes. Moreover, AA PC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::869cac917c76326b23e45964e4cf5fdd
https://doi.org/10.1200/jco.2021.39.6_suppl.16
https://doi.org/10.1200/jco.2021.39.6_suppl.16
Autor:
Heidi Dowst, Attiya Batool Noor, Guilherme Godoy, Maria A Berezina, Samantha Cohen, Alexander D Le, Anna Ewa Schwarzbach, Tamer Khashab, Michael Brooks, Neda Zarrin-Khameh, Nicholas Mitsiades, Michael E. Scheurer, Martha P. Mims, Salma Kaochar
Publikováno v:
Journal of Clinical Oncology. 39:14-14
14 Background: The largest US cancer health disparity exists in prostate cancer (PC), with African American (AA) men having: ~1.6-1.8-fold higher risk of developing PC; younger age and more advanced stage at diagnosis; increased risk of recurrence af
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cba0c01efa309b3e964765f556f8cef1
https://doi.org/10.1200/jco.2021.39.6_suppl.14
https://doi.org/10.1200/jco.2021.39.6_suppl.14
Autor:
Felipe Samaniego, R. Eric Davis, Stefan Köhrer, Sattva S. Neelapu, Tamer Khashab, Ondrej Havranek, Lalit Sehgal, Rohit Mathur, Neeraj Jain, Jan A. Burger
Publikováno v:
Haematologica. 102:373-380
Histone methylation and demethylation regulate B-cell development, and their deregulation correlates with tumor chemoresistance in diffuse large B-cell lymphoma, limiting cure rates. Since histone methylation status correlates with disease aggressive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cd5e39fc8c47daa4362930ced53363b
https://doi.org/10.3324/haematol.2016.144964
https://doi.org/10.3324/haematol.2016.144964
Autor:
Jorge E. Romaguera, Anas Younes, Lei Feng, Tamer Khashab, Sattva S. Neelapu, Francisco Vega, Felipe Samaniego, Fredrick B. Hagemeister, Luis Fayad, Barbara Pro, Larry W. Kwak, Michelle A. Fanale, Peter McLaughlin, M. Alma Rodriguez
Publikováno v:
British journal of haematology. 185(4)
In a prospective phase II trial, pentostatin combined with cyclophosphamide and rituximab (PCR) induced strong responses and was well-tolerated in previously untreated patients with advanced-stage, indolent non-Hodgkin lymphoma (iNHL). After a median
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::605a12f7490d5019fa587e68aaad6446
https://pubmed.ncbi.nlm.nih.gov/30820940
https://pubmed.ncbi.nlm.nih.gov/30820940